Dr. Castillo's testosterone pellet claims need context

What did @dr.reynoldscastillo actually say?

Honestly, almost nothing clinically useful. The transcript is a series of filler phrases recorded in April 2019, with no actual medical content: "I hope you enjoy this video" repeated three times, followed by a sign-off. The real claims live in the caption, not the video itself. The caption promises that testosterone pellets address "cansancio, baja energía o disminución del deseo" (fatigue, low energy, reduced desire), framed as a direct solution: "Es momento de recuperar tu fuerza y bienestar." That is a marketing promise, not a clinical explanation. There is no discussion of who qualifies, what lab values matter, or what the risks are. The hashtags "rejuvchip" and "chipdelajuventud" (chip of youth) are brand-adjacent and carry strong anti-aging connotations that go well beyond what the evidence supports. So we are fact-checking a caption and a hashtag strategy more than a medical lecture.

Does the science back this up?

Partly, but the framing oversimplifies a complicated clinical picture. Testosterone replacement therapy (TRT) does have evidence for treating hypogonadism, and pellet delivery is a legitimate method, though not the most studied one. The problem is the symptom list.

Fatigue and low libido are two of the least specific symptoms in medicine. They overlap with depression, sleep apnea, thyroid dysfunction, anemia, and dozens of other conditions. Bhasin et al. (2010, New England Journal of Medicine) established that TRT improves sexual function in men with confirmed low testosterone, but the effect sizes on energy and mood are modest and inconsistent. A Cochrane review by Huo et al. (2016) found limited evidence that TRT meaningfully improves quality-of-life outcomes beyond sexual function in older men.

Pellet-specific data is thinner. Pellets are not FDA-approved for men in the United States, though they are used off-label. A retrospective study by Donovitz and Cotten (2021, European Journal of Medical Research) reported symptom improvement with pellets, but that study had significant methodological limitations including no control group.

What did they get wrong (or right)?

What they got right: testosterone pellets are a real delivery method, subcutaneous implantation does provide more stable serum levels than some other formulations, and low testosterone is a genuine clinical condition worth treating when properly diagnosed. Credit where it is due.

What they got wrong is the framing. Presenting fatigue, low energy, and reduced desire as symptoms that signal "it is time" for a testosterone pellet skips the entire diagnostic process. You need bloodwork. You need a free and total testosterone level drawn in the morning. You need to rule out secondary causes. Miner et al. (2014, Mayo Clinic Proceedings) found that up to 25 percent of men referred for TRT had a reversible underlying cause that was missed on initial workup.

The "chip of youth" branding is also a red flag. Anti-aging marketing attached to hormone therapy has a poor track record of accuracy and a strong track record of overselling. The Endocrine Society's 2018 clinical practice guidelines explicitly warn against prescribing testosterone to men with age-related decline in the absence of confirmed hypogonadism.

What should you actually know?

If you are experiencing fatigue or low libido, testosterone is not the default answer. It might not even be in the top five things to investigate first. Start with a primary care visit and basic labs before anyone recommends a pellet implant.

For men who do have confirmed hypogonadism (generally defined as total testosterone below 300 ng/dL with symptoms, per American Urological Association guidelines), TRT can be genuinely effective. Pellets are one option, but they come with specific tradeoffs: dosing cannot be adjusted once implanted, insertion carries a small risk of infection or extrusion, and hormone levels can vary more than manufacturers suggest.

• Always confirm diagnosis with at least two early-morning testosterone measurements before starting TRT.
• Pellet dosing is not reversible for the 3-6 month duration of the implant. That matters if you have side effects.
• TRT can suppress fertility. If you want children, discuss this with your provider before starting.
• Hematocrit should be monitored. TRT increases red blood cell production, which raises clot risk if unchecked (Fernandez-Balsells et al., 2010, Journal of Clinical Endocrinology and Metabolism).

A TikTok caption is not a diagnosis. A gynecologist posting about male hormone therapy in Lima is not automatically wrong, but the absence of any clinical nuance here is a real problem for 31,600 viewers who may not know what questions to ask.